Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Carbohydrate quality and human health: a series of systematic reviews and meta-analysesThe Lancet (British edition), 2019-02, Vol.393 (10170), p.434-445 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31809-9 ;PMID: 30638909Full text available |
|
2 |
Material Type: Article
|
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort studyThe Lancet (British edition), 2020-07, Vol.396 (10244), p.97-109 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30543-2 ;PMID: 32445693Full text available |
|
3 |
Material Type: Article
|
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trialsThe Lancet (British edition), 2018-10, Vol.392 (10155), p.1311-1320 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31652-0 ;PMID: 30293769Full text available |
|
4 |
Material Type: Article
|
The rise and fall of aspirin in the primary prevention of cardiovascular diseaseThe Lancet (British edition), 2019-05, Vol.393 (10186), p.2155-2167 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)30541-0 ;PMID: 31226053Full text available |
|
5 |
Material Type: Article
|
Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individualsThe Lancet (British edition), 2015, Vol.386 (10005), p.1739-1746 [Peer Reviewed Journal]Kivimäki et al. Open Access article distributed under the terms of CC BY ;2015 Kivimäki et al. Open Access article distributed under the terms of CC BY ;Copyright © 2015 Kivimäki et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Oct 31, 2015 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)60295-1 ;PMID: 26298822Full text available |
|
6 |
Material Type: Article
|
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation studyThe Lancet (British edition), 2018-05, Vol.391 (10133), p.1897-1907 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)30664-0 ;PMID: 29735391Full text available |
|
7 |
Material Type: Article
|
Family health history: underused for actionable risk assessmentThe Lancet (British edition), 2019-08, Vol.394 (10198), p.596-603 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31275-9 ;PMID: 31395442Full text available |
|
8 |
Material Type: Article
|
Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future optionsThe Lancet (British edition), 2019-08, Vol.394 (10199), p.697-708 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31950-6 ;PMID: 31448741Full text available |
|
9 |
Material Type: Article
|
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trialThe Lancet (British edition), 2018-11, Vol.392 (10161), p.2269-2279 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 24, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32328-6 ;PMID: 30293771Full text available |
|
10 |
Material Type: Article
|
Is intima-media thickness a predictor for cardiovascular risk? – Authors' replyThe Lancet (British edition), 2019-08, Vol.394 (10196), p.381-381 [Peer Reviewed Journal]2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)30343-5 ;PMID: 31379329Full text available |
|
11 |
Material Type: Article
|
Hot weather and heat extremes: health risksThe Lancet (British edition), 2021-08, Vol.398 (10301), p.698-708 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01208-3 ;PMID: 34419205Full text available |
|
12 |
Material Type: Article
|
Prevention of premature cardiovascular death worldwideThe Lancet (British edition), 2020-03, Vol.395 (10226), p.758-760 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32034-3 ;PMID: 31492506Full text available |
|
13 |
Material Type: Article
|
Is it time to include cancer in cardiovascular risk prediction tools?The Lancet (British edition), 2019-09, Vol.394 (10203), p.986-988 [Peer Reviewed Journal]2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31886-0 ;PMID: 31443925Full text available |
|
14 |
Material Type: Article
|
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet (British edition), 2020-02, Vol.395 (10225), p.709-733 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access Article under the CC BY 4.0 license. ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access Article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access Article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access Article under the CC BY 4.0 license. 2020 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30045-3 ;PMID: 32061315Full text available |
|
15 |
Material Type: Article
|
Efficacy of folic acid supplementation in stroke prevention: a meta-analysisThe Lancet (British edition), 2007-06, Vol.369 (9576), p.1876-1882 [Peer Reviewed Journal]Elsevier Ltd ;2007 Elsevier Ltd ;Copyright Elsevier Limited Jun 2-Jun 8, 2007 ;Copyright Elsevier Limited Jun 2, 2007 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(07)60854-X ;PMID: 17544768 ;CODEN: LANCAOFull text available |
|
16 |
Material Type: Article
|
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort studyThe Lancet, 2020-05, Vol.395 (10238), p.1715-1725 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30854-0 ;PMID: 32405103Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational studyThe Lancet (British edition), 2018-05, Vol.391 (10132), p.1775-1782 [Peer Reviewed Journal]2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited May 5, 2018 ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)30668-8 ;PMID: 29706364Full text available |
|
18 |
Material Type: Article
|
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort studyThe Lancet (British edition), 2020-03, Vol.395 (10226), p.785-794 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32007-0 ;PMID: 31492501Full text available |
|
19 |
Material Type: Article
|
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trialThe Lancet (British edition), 2021-11, Vol.398 (10313), p.1811-1824 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02188-7 ;PMID: 34672967Full text available |
|
20 |
Material Type: Article
|
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trialThe Lancet (British edition), 2021-05, Vol.397 (10289), p.2060-2069 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00520-1 ;PMID: 34015342Full text available |